Generation and Characterization of the First Persistent Platinum(I)‐Centered Radical

The first persistent platinum(I)‐centered radical was generated by homolytic cleavage of a Pt?HgSiR₃ bond of a mercury‐substituted platinum(II) complex. The Pt^I radical was characterized by EPR spectroscopy, chemical trapping experiments, and density functional theory (DFT) calculations.     

CO oxidation over a Pt-Rh system. 1. Reaction on individual metals

The reaction of CO oxidation over thin films of rhodium and platinum prepared by vacuum evaporation of the metals on an inert support has been investigated at low pressures (P < 2×10^-5 mbar). Rhodium has been found to be more active than platinum in this reaction. The reasons of the higher activity of Rh are discussed.     

Standard enthalpy of formation of platinum hydrous oxide

Standard enthalpies of formation of amorphous platinum hydrous oxide PtH_2.76O_3.89 (Adams' catalyst) and dehydrated oxide PtO_2.52 at T=298.15 K were determined to be -519.6±1.0 and -101.3 ±5.2 kJ mol^-1, respectively, by micro-combustion calorimetry. Standard enthalpy of formation of anhydrous PtO₂ was estimated to be -80 kJ mol^-1 based on the calorimetry. A meaningful linear relationship was found between the pseudo-atomization enthalpies of platinum oxides and the coordination number of oxygen surrounding platinum. This relationship indicates that the Pt-O bond dissociation energy is 246 kJ mol^-1 at T=298.15 K which is surprisingly independent of both the coordination number and the valence of platinum atom. This may provide an energetic reason why platinum hydrous oxide is non-stoichiometric. This revised version was published online in August 2006 with corrections to the Cover Date.     

Occlusion of hydrogen in electrodeposited platinum layers

Occlusion of hydrogen in platinized platinum electrodes has been studied in 1 mol/dm³ H₂SO₄ electrolyte. It has been found that the amount of hydrogen dissolved in the platinum layer depends on the structure of the Pt deposit, which is determined by the parameters of electrodeposition. Composition of the platinizing solution as well as the potential of Pt deposition are decisive parameters. On the basis of experimental results it is assumed that occlusion of hydrogen takes place in special structural elements of the platinum layer which are formed in the course of Pt deposition. Hydrogen dissolution versus H-deposition potential, H-deposition time and Pt layer thickness relationships are also presented. Received: 2 March 1999 / Accepted: 25 May 1999     

γ-Zirconium and γ-Titanium Phosphates Platinum Intercalation Compound Preparation, characterization and thermal behaviour

Inorganic ion-exchangers with a layered structure such as γ-zirconium and γ-titanium phosphates, intercalated with organic diamines, are able to exchange Pt²⁺ ions to give new intercalation compounds that can be utilized in heterogeneous catalysis. The experiments performed at different temperatures (25 and 45°C), show different ion uptakes, greater at 45°C and for the materials derived from γ-zirconium phosphate. After platinum exchange, all the materials show an amorphization in the XRD if compared with their precursors. The thermal behaviour of the platinum materials is specific, depending on the exchanger used and the ligand inside the exchanger. Pt²⁺ ion has a catalytic effect on ligand elimination in the γ-zirconium phosphate platinum compounds, but not in those derived from γ-titanium. All the obtained yellow materials show a small step in the TG curves and simultaneously we have the Pt²⁺→Pt⁰ reduction: this is confirmed by XRD registered at the temperatures of the thermal effect, showing peaks at d_hkl=2.27 and 1.95 Å. This revised version was published online in July 2006 with corrections to the Cover Date.     

Bioinspired Hierarchical Nanotubular Titania Immobilized with Platinum Nanoparticles for Photocatalytic Hydrogen Production

A bioinspired nanocomposite composed of platinum nanoparticles and nanotubular titania was fabricated in which the titania matter was templated by natural cellulose substance. The composite possesses three‐ dimensional hierarchical structures, and ultrafine metallic platinum particles with sizes of ca. 2 nm were immobilized uniformly on the surfaces of the titania nanotubes. Such a nanocomposite with 1.06 wt % of platinum content shows the optimal photocatalytic hydrogen production activity from water splitting of 16.44 mmol h^?1 g^?1, and excessive loading of platinum results in poorer photocatalytic performance. The structural integrity of the nanocomposite upon cyclic water‐splitting processes results in its sufficient photocatalytic stability.     

Photoinduced Reduction of PtIV within an Anti‐Proliferative PtIV–Texaphyrin Conjugate

In an effort to increase the stability and control the platinum reactivity of platinum–texaphyrin conjugates, two Pt^IV conjugates were designed, synthesized, and studied for their ability to form DNA adducts. They were also tested for their anti‐proliferative effects using wild‐type and platinum‐resistant human ovarian cancer cell lines (A2780 and 2780CP, respectively). In comparison to an analogous first‐generation Pt^II chimera, one of the new conjugates provided increased stability in aqueous environments. Using a combination of ¹H NMR spectroscopy and FAAS (flameless atomic‐absorption spectrometry), it was found that the Pt^IV center within this conjugate undergoes photoinduced reduction to Pt^II upon exposure to glass‐filtered daylight, resulting in an entity that binds DNA in a controlled manner. Under conditions in which the Pt^IV complex is reduced to the corresponding Pt^II species, these new conjugates demonstrated potent anti‐proliferative activity in both test ovarian cancer cell lines.     

Solution Behaviour and Biomolecular Interactions of Two Cytotoxic trans‐Platinum(II) Complexes Bearing Aliphatic Amine Ligands

A novel trans‐platinum(II) complex bearing one dimethylamine (dma) and one methylamine (ma) ligand, namely trans‐[PtCl₂(dma)(ma)], recently synthesised and characterised in our laboratory, displayed relevant antiproliferative properties in vitro, being more active than the parent complex, trans‐[PtCl₂(dma)(ipa)], which has isopropylamine (ipa) in place of methylamine. We have analysed comparatively the solution behaviour of these two complexes under various experimental conditions, and investigated their reactivity with horse heart cytochrome c by mass spectrometry, inductively coupled plasma–optical emission spectroscopy (ICP‐OES), 2D [¹H,¹⁵N],[¹H,¹³C] HSQC and [¹H,¹H] NOESY NMR. Some important changes that occurred in the [¹H,¹³C] HSQC NMR spectrum of cytochrome c treated with trans‐[PtCl₂(dma)(ma)] in water, after two days’ incubation, most probably arose from direct platinum coordination to the protein side chain; this was proved conclusively by [¹H,¹H] NOESY NMR and [¹H,¹⁵N] HSQC NMR measurements. Met65 was identified as the primary Pt binding site on cytochrome c. Electrospray mass spectrometry (ESIMS) results provided evidence for extensive platinum–protein adduct formation. A fragment of the [Pt(amine)(amine′)] type was established to be primarily responsible for protein metalation. ICP‐OES analysis revealed that these trans‐platinum(II) complexes bind preferentially to the serum proteins albumin and transferrin rather than to calf thymus DNA. Pt binding to DNA was found to be far lower than in the case of cisplatin. The implications of the results for the mechanism of action of novel cytotoxic trans‐platinum complexes are discussed.     

Human Serum Albumin Conjugated Nanoparticles for pH and Redox‐Responsive Delivery of a Prodrug of Cisplatin

Platinum anticancer drugs are particularly in need of controlled drug delivery because of their severe side effects. Platinum(IV) agents are designed as prodrugs to reduce the side effects of platinum(II) drugs; however, premature reduction could limit the effect as a prodrug. In this work, a highly biocompatible, pH and redox dual‐responsive delivery system is prepared by using hybrid nanoparticles of human serum albumin (HSA) and calcium phosphate (CaP) for the Pt^IV prodrug of cisplatin. This conjugate is very stable under extracellular conditions, so that it protects the platinum(IV) prodrug in HSA. Upon reaching the acidic and hypoxic environment, the platinum drug is released in its active form and is able to bind to the target DNA. The Pt–HSA/CaP hybrid inhibits the proliferation of various cancer cells more efficiently than cisplatin. Different cell cycle arrests suggest different cellular responses of the Pt^IV prodrug in the CaP nanocarrier. Interestingly, this delivery system demonstrates enhanced cytotoxicity to tumor cells, but not to normal cells.     

Synthesis and spectroscopic characteristics of σ-vinyl derivatives of platinum(<Emphasis Type="SmallCaps">IV</Emphasis>) chloride complexes

A procedure was developed for the synthesis of previously unknown β-chlorovinyl derivatives of Pt^IV chloride complexes by chloroplatination of terminal alkynes catalyzed by Pt^II chloride complexes. The reaction is highly stereoselective and gives only the products of trans-anti-addition of platinum and chlorine atoms. The regioselectivity of the catalytic reaction formally corresponds to Markovnikov’s rule, e.g., in alkynes containing electron-donating substituents, platinum attacks the terminal carbon atom. The σ-vinyl derivatives of Pt^IV chloride complexes were characterized by IR spectroscopy and ¹H and ¹³C NMR spectroscopy. Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 10, pp. 2380–2384, October, 2005.     

Structural Evidence for Pnictogen-Centered Lewis Acidity in Cationic Platinum-Stibine Complexes Featuring Pendent Amino or Ammonium Groups

As part of our continuing interest in the chemistry of cationic antimony Lewis acids as ligands for late transition metals, we have now investigated the synthesis of platinum complexes featuring a triarylstibine ligand substituted by an o-[(dimethylamino)methyl]phenyl group referred to as Ar^N. More specifically, we describe the synthesis of the amino stibine ligand Ph₂SbAr^N (L) and its platinum dichloride complex [LPtCl]Cl which exists as a chloride salt and which shows weak coordination of the amino group to the antimony center. We also report the conversion of [LPtCl]Cl into a tricationic complex [LHPt(SMe₂)]³⁺ which has been isolated as a tris-triflate salt after reaction of [LPtCl]Cl with SMe₂, HOTf and AgOTf. Finally, we show that [LHPt(SMe₂)][OTf]₃ acts as a catalyst for the cyclization of 2-allyl-2-(2-propynyl)malonate.     

Surface and Subsurface Oxygen on Platinum in a Perchloric Acid Solution

The oxidation of polycrystalline platinum in perchloric acid is studied by cyclic voltammetry at a potential scan rate of 0.1 V s^–1 in various potential cycling ranges. The earlier model for the formation of a barrier layer of strong complexes consisting of subsurface oxygen O_ss, platinum atoms, and anions adsorbed on the latter is shown to correctly describe experimental results on the platinum oxidation in sulfuric and perchloric acids. The regularities in these acids are on the whole similar. A weaker adsorption of perchlorate anions as compared with bisulfate facilitates chemisorption of oxygen at 0.7–0.85 V and hinders exchange by sites Pt O at 0.85–1.35 V. A prolonged potential cycling with a cathodic limit of 0.27 V and low anodic limits leads to the accumulation of surface complexes O_ss–Pt _n –ClO₄, which hinder both the oxygen chemisorption and the exchange Pt O below 1 V. At more positive potentials, the complexes are destroyed and oxygen penetrates into subsurface platinum layers.     

氧-硼共修饰多壁碳纳米管载铂催化剂的制备及氧还原活性

采用一种简便的方法,合成了氧-硼共修饰的多壁碳纳米管材料,以此为载体制备的铂基催化剂具有更小的铂粒径、更高的电化学表面积(40 m²·g_Pt^-1)和更高的氧还原活性(0.3 A·mg_Pt^-1)。氧、硼在提高碳纳米管的载体分散性、控制铂颗粒的均匀性和粒径、促进氧还原反应的氧吸附/解离方面发挥着重要的作用。     

Mechanism of PtIV Sonochemical Reduction in Formic Acid Media and Pure Water

Sonochemical synthesis of platinum nanoparticles (Pt NPs) in formic acid solutions and pure water was investigated using a 20 kHz ultrasonic irradiation. The obtained results gave new insights on the underneath Pt^IV reduction mechanism in formic acid media under argon and in pure water under Ar/CO atmosphere. It was shown that in pure water sonochemical reduction of platinum ions occurs by hydrogen issued from homolytic water molecule split. Pt^IV ion reduction appears to be a very slow process under argon atmosphere in pure water due to formation of oxidizing species like OH radicals and H₂O₂ leading to reoxidation of intermediate Pt^II ions. Sonochemical reduction is accelerated manifold in the presence of formic acid or Ar/CO gas mixture. Solution and gas‐phase analyses reveal that both CO and HCOOH act as OH^. radical scavenger and reducing agent under ultrasonic irradiation. Their ability to reduce platinum ions at room temperature is enhanced due to the local heating in the liquid shell surround the cavitation bubble. An innovative synthesis route for monodispersed Pt NPs in pure water without any templates or capping agents in the presence of Ar/CO gas mixture is then proposed. Obtained Pt NPs within the range of 2–3 nm exhibited a strong stability towards sedimentation in water. Since Ar/CO atmosphere is the only restriction of the process, this procedure can be applied in various media and is also compatible with a large array of experimental conditions.     

氧-硼共修饰多壁碳纳米管载铂催化剂的制备及氧还原活性

采用一种简便的方法,合成了氧-硼共修饰的多壁碳纳米管材料,以此为载体制备的铂基催化剂具有更小的铂粒径、更高的电化学表面积(40 m²·g_Pt^-1)和更高的氧还原活性(0.3 A·mg_Pt^-1)。氧、硼在提高碳纳米管的载体分散性、控制铂颗粒的均匀性和粒径、促进氧还原反应的氧吸附/解离方面发挥着重要的作用。     

Nucleotide Binding Preference of the Monofunctional Platinum Anticancer‐Agent Phenanthriplatin

The monofunctional platinum anticancer agent phenanthriplatin generates covalent adducts with the purine bases guanine and adenine. Preferential nucleotide binding was investigated by using a polymerase stop assay and linear DNA amplification with a 163‐base pair DNA double helix. Similarly to cisplatin, phenanthriplatin forms the majority of adducts at guanosine residues, but significant differences in both the number and position of platination sites emerge when comparing results for the two complexes. Notably, the monofunctional complex generates a greater number of polymerase‐halting lesions at adenosine residues than does cisplatin. Studies with 9‐methyladenine reveal that, under abiological conditions, phenanthriplatin binds to the N¹ or N⁷ position of 9‐methyladenine in approximately equimolar amounts. By contrast, comparable reactions with 9‐methylguanine afforded only the N⁷‐bound species. Both of the 9‐methyladenine linkage isomers (N¹ and N⁷) exist as two diastereomeric species, arising from hindered rotation of the aromatic ligands about their respective platinum–nitrogen bonds. Eyring analysis of rate constants extracted from variable‐temperature NMR spectroscopic data revealed that the activation energies for ligand rotation in the N¹‐bound platinum complex and the N⁷‐linkage isomers are comparable. Finally, a kinetic analysis indicated that phenanthriplatin reacts more rapidly, by a factor of eight, with 9‐methylguanine than with 9‐methyladenine, suggesting that the distribution of lesions formed on double‐stranded DNA is kinetically controlled. In addition, implications for the potent anticancer activity of phenanthriplatin are discussed herein.     

Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of 193mPt and 195mPt Radionuclides in Auger Electron Therapy

^193mPt and ^195mPt radionuclides are therapeutically attractive Auger electron emitters with notably high Auger electron yield per decay. The present paper summarizes the first step of research on the applications of core-shell (Au@Pt) nanoparticles for electron Auger therapy of HER2+ (human epidermal growth factor receptor 2) breast cancer and hepatocellular carcinoma. Gold nanoparticles (30 nm) were synthesized covered with a platinum shell at high efficiency (>80%) and were further evaluated for in vitro studies such as binding affinity, internalization and cytotoxicity. To find the mechanism(s) responsible for platinum cytotoxicity in HepG2 cells, the platinum concentration in isolated cell nuclei and cytoplasm was determined using ICP-MS (inductively coupled plasma mass spectrometry). Lack of platinum in cell nuclei suggests that the cytotoxic effect is associated with the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). Studies carried out on the SKOV-3 cell line with the use of a synthesized targeting bioconjugate (Au@Pt-PEG-trastuzumab) revealed a high affinity of this preparation to HER2+ cells, its internalization, its placement in the perinuclear area and partial intranuclear location. The specific binding for HER2 negative cells, MDA-MB-231, was negligible and Au@Pt-PEG-trastuzumab did not enter these cells. The results obtained are promising and warrant future investigation of Auger electron therapy using ^193mPt and ^195mPt based radiopharmaceuticals.     

A facile one‐pot synthesis of [(COD)Pt(CH3)2]

A novel one‐pot synthesis of dimethyl(1,5‐cyclooctadiene)platinum(II), i.e. [(COD)Pt(CH₃)₂] (complex 1), was developed in 92% yield using platinum acetylacetonate, 1,5‐cyclooctadiene and trimethylaluminium. Complex 1 was fully characterized by ¹H and ¹³C NMR, mass spectrometry, cell dimensions and elemental analysis. Copyright © 2005 John Wiley & Sons, Ltd.     

A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases

We report toxic effects of a photoactivatable platinum(IV) complex conjugated with suberoyl‐bis‐hydroxamic acid in tumor cells. The conjugate exerts, after photoactivation, two functions: activity as both a platinum(II) anticancer drug and histone deacetylase (HDAC) inhibitor in cancer cells. This approach relies on the use of a Pt^IV pro‐drug, acting by two independent mechanisms of biological action in a cooperative manner, which can be selectively photoactivated to a cytotoxic species in and around a tumor, thereby increasing selectivity towards cancer cells. These results suggest that this strategy is a valuable route to design new platinum agents with higher efficacy for photodynamic anticancer chemotherapy.     

Organoplatinum(II) Complexes with Nucleobase Motifs as Inhibitors of Human Topoisomerase II Catalytic Activity

Platinum(II) complexes bearing acetylide ligands containing nucleobase motifs are prepared and their impact on human topoisomerase II (TopoII) is evaluated. Both platinum(II) complexes [Pt^II(C^N^N)(C≡CCH₂R)] ( 1a , 1b , 1c ) and [Pt^II(tBu₃terpy)(C≡CCH₂R)]⁺ ( 2a , 2b , 2c ) (C^N^N=6‐phenyl‐2,2′‐bipyridyl, tBu₃terpy = 4,4′,4′′‐tri‐tert‐butyl‐2,2′:6′,2′′‐terpyridyl, and R=( a ) adenine, ( b ) thymine, and ( c ) 2‐amino‐6‐chloropurine) are stable in aqueous solutions for 48 hours at room temperature. The binding constants (K) for the platinum(II) complexes towards calf thymus DNA are in the order of 10⁵ dm³ mol^?1 as estimated by using UV/Vis absorption spectroscopy. Of the complexes examined, only complexes 1a , 1b , 1c are found to behave as intercalators. Both complexes 1a , 1b , 1c and 2a , 2b , 2c inhibit TopoII‐induced relaxation of supercoiled DNA, while 2c is the most potent TopoII inhibitors among the tested compounds. Inhibition of DNA relaxation is detected at nanomolar concentrations of 2c . All of the platinum(II) complexes are cytotoxic to human cancer cells with IC₅₀ values of 0.5–13.7 μM , while they are less toxic against normal cells CCD‐19 Lu.